SYRE · Spyre Therapeutics, Inc.
$87.50
+0.25 (+0.29%)
At close · Sep 4
Going-concern doubt
— flagged Aug 4, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We will need to raise additional capital to continue to fund our operations in the future. If we are unable to raise additional capital when needed, we will not be able to continue as a going concern.”View the 10-Q filed Aug 4, 2026
Market Cap
$7.54B
Shares
88.17M
Stock transactions by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this stock yet.
Key facts
CIK
1636282
CUSIP
00773J202
13F (30d)
234 filings
231 filers
Visit website
Investor relations